Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas

What this Trial Is About

Researchers are developing a comprehensive clinical and biological database focused on various types of cancer, including digestive, gynecologic, breast cancers, and sarcomas. This database supports research in epidemiology, biology, and clinical trials by helping scientists understand tumor behavior, from molecular interactions to metabolism in healthy and diseased states. It aims to identify new strategies for cancer prevention, diagnosis, and treatment by providing reliable clinical and biological data. The study collects biological samples such as frozen tumor and healthy tissues during surgery and blood samples taken at different times for diagnostic and treatment purposes, including additional samples for research. Alongside this biological collection, standardized clinical data are systematically entered into a database. This integrated approach facilitates multidisciplinary research, harmonizing data collection and sharing to support medical progress and the identification of molecular markers. Participants are patients aged 18 or older with confirmed or suspected invasive or in situ tumors of digestive, gynecologic, breast, or sarcoma cancers, who have not yet received treatment and require tumor surgery. Researchers measure the proportion of patients consenting to participate over about one year. The study involves ongoing assessments through biological samples and clinical data collection, enabling long-term research and monitoring to enhance understanding and innovation in cancer care.

Development of Clinical and Biological Database